Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D, Xie XP, Zhang X, Wang Z, Sait SF, Iyer SV, Chen YJ, Brown R, Laks DR, Chipman ME, Shern JF, Parada LF.
Cell Stem Cell. 2021 Aug 5;28(8):1397-1410.e4. doi: 10.1016/j.stem.2021.04.029. Epub 2021 May 18.
The NF1 somatic mutational landscape in sporadic human cancers.
Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M.
Hum Genomics. 2017 Jun 21;11(1):13. doi: 10.1186/s40246-017-0109-3.
[Neurofibromatosis].
Matthies C, Rampeltshammer E, Breun M.
Fortschr Neurol Psychiatr. 2023 May;91(5):213-232. doi: 10.1055/a-2000-3713. Epub 2023 May 16.
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG, Mostaccioli S, Pang D, Fadzil O Connor M, Pittara M, Champollion N, Wolkenstein P, Thomas N, Ferner RE, Kalamarides M, Peyre M, Papi L, Legius E, Becerra JL, King A, Duff C, Stivaros S, Blanco I.
Eur J Hum Genet. 2022 Jul;30(7):812-817. doi: 10.1038/s41431-022-01086-x. Epub 2022 Apr 1.
Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C, McKay RM, Lee SY, Romo CG, Blakeley JO, Haniffa M, Serra E, Steensma MR, Largaespada D, Le LQ.
J Invest Dermatol. 2023 Aug;143(8):1369-1377. doi: 10.1016/j.jid.2022.12.027. Epub 2023 Jun 15.
[Long-term epilepsy-associated tumors].
Kopachev DN, Shishkina LV, Shkatova AM, Golovteev AL, Troitsky AA, Grinenko OA, Sharkova SM, Petrosyan DV, Gushcha AO.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(4):127-134. doi: 10.17116/jnevro2022122041127.
Kolloidcyster i tredje hjerneventrikkel.
Aarhus M, Rønning P, Vik-Mo EO, Marthinsen PB, Ramm-Pettersen J, Eide PK, Helseth E.
Tidsskr Nor Laegeforen. 2025 Feb 4;145(2). doi: 10.4045/tidsskr.24.0500. Print 2025 Feb 11.
[Pineal cyst].
Abramov IT, Pitskhelauri DI, Serova NK.
Zh Vopr Neirokhir Im N N Burdenko. 2017;81(4):113-120. doi: 10.17116/neiro2017814113-120.
Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.
Jiang C, Kumar A, Yu Z, Shipman T, Wang Y, McKay RM, Xing C, Le LQ.
J Clin Invest. 2023 Jun 15;133(12):e168227. doi: 10.1172/JCI168227.
Orbital malign trichilemmal tumor with cerebral involvement.
Ogul H, Keles S, Yildirim K, Bassorgun CI, Eren S, Kantarci M.
J Craniofac Surg. 2014 Jan;25(1):e21-3. doi: 10.1097/SCS.0b013e3182a2ed5a.
